vs
Side-by-side financial comparison of NB Bancorp, Inc. (NBBK) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $63.4M, roughly 1.3× NB Bancorp, Inc.). NB Bancorp, Inc. runs the higher net margin — 12.2% vs -38.1%, a 50.2% gap on every dollar of revenue. On growth, NB Bancorp, Inc. posted the faster year-over-year revenue change (33.9% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 22.6%).
NB Bancorp, Inc. is a U.S.-based bank holding company operating through its fully owned banking subsidiary. It provides a full range of retail and commercial banking services including various deposit products, consumer loans, residential mortgages, and small business financing solutions, primarily catering to individual and small-to-mid-sized enterprise customers across the New York metropolitan area.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
NBBK vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $63.4M | $83.1M |
| Net Profit | $7.7M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 23.5% | -4.1% |
| Net Margin | 12.2% | -38.1% |
| Revenue YoY | 33.9% | 20.2% |
| Net Profit YoY | -50.6% | -27.9% |
| EPS (diluted) | $0.19 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $63.4M | $76.4M | ||
| Q3 25 | $51.7M | $83.3M | ||
| Q2 25 | $51.2M | $79.2M | ||
| Q1 25 | $47.4M | $69.2M | ||
| Q4 24 | $47.3M | $68.2M | ||
| Q3 24 | $42.6M | $58.4M | ||
| Q2 24 | $41.7M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $7.7M | $-29.8M | ||
| Q3 25 | $15.4M | $-21.4M | ||
| Q2 25 | $14.6M | $-19.6M | ||
| Q1 25 | $12.7M | $-24.7M | ||
| Q4 24 | $15.6M | $-18.9M | ||
| Q3 24 | $8.4M | $-21.0M | ||
| Q2 24 | $9.5M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 23.5% | -40.6% | ||
| Q3 25 | 38.6% | -27.8% | ||
| Q2 25 | 36.6% | -28.0% | ||
| Q1 25 | 37.1% | -39.7% | ||
| Q4 24 | 40.7% | -28.9% | ||
| Q3 24 | 36.1% | -38.4% | ||
| Q2 24 | 28.3% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 12.2% | -39.1% | ||
| Q3 25 | 29.7% | -25.7% | ||
| Q2 25 | 28.5% | -24.7% | ||
| Q1 25 | 26.7% | -35.8% | ||
| Q4 24 | 33.0% | -27.6% | ||
| Q3 24 | 19.7% | -35.9% | ||
| Q2 24 | 22.7% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.19 | $-0.54 | ||
| Q3 25 | $0.43 | $-0.38 | ||
| Q2 25 | $0.39 | $-0.35 | ||
| Q1 25 | $0.33 | $-0.45 | ||
| Q4 24 | $0.40 | $-0.34 | ||
| Q3 24 | $0.21 | $-0.40 | ||
| Q2 24 | $0.24 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $858.9M | $347.7M |
| Total Assets | $7.0B | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $858.9M | $365.9M | ||
| Q3 25 | $737.0M | $380.3M | ||
| Q2 25 | $737.1M | $385.8M | ||
| Q1 25 | $739.6M | $389.2M | ||
| Q4 24 | $765.2M | $402.2M | ||
| Q3 24 | $747.4M | $241.2M | ||
| Q2 24 | $734.3M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $7.0B | $508.1M | ||
| Q3 25 | $5.4B | $511.5M | ||
| Q2 25 | $5.2B | $513.1M | ||
| Q1 25 | $5.2B | $519.4M | ||
| Q4 24 | $5.2B | $534.0M | ||
| Q3 24 | $5.0B | $374.1M | ||
| Q2 24 | $4.8B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $60.8M | — |
| Free Cash FlowOCF − Capex | $57.4M | — |
| FCF MarginFCF / Revenue | 90.6% | — |
| Capex IntensityCapex / Revenue | 5.4% | — |
| Cash ConversionOCF / Net Profit | 7.89× | — |
| TTM Free Cash FlowTrailing 4 quarters | $117.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $60.8M | $-10.3M | ||
| Q3 25 | $24.2M | $-6.6M | ||
| Q2 25 | $27.0M | $-15.0M | ||
| Q1 25 | $9.9M | $-17.0M | ||
| Q4 24 | $43.2M | $-32.4M | ||
| Q3 24 | $8.6M | $-18.8M | ||
| Q2 24 | $24.7M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $57.4M | $-12.2M | ||
| Q3 25 | $23.9M | $-9.5M | ||
| Q2 25 | $26.1M | $-17.8M | ||
| Q1 25 | $9.8M | $-18.8M | ||
| Q4 24 | $41.3M | $-33.6M | ||
| Q3 24 | $8.4M | $-19.0M | ||
| Q2 24 | $23.8M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 90.6% | -15.9% | ||
| Q3 25 | 46.3% | -11.4% | ||
| Q2 25 | 51.0% | -22.5% | ||
| Q1 25 | 20.8% | -27.2% | ||
| Q4 24 | 87.2% | -49.2% | ||
| Q3 24 | 19.7% | -32.6% | ||
| Q2 24 | 57.1% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | 2.4% | ||
| Q3 25 | 0.6% | 3.4% | ||
| Q2 25 | 1.9% | 3.5% | ||
| Q1 25 | 0.2% | 2.7% | ||
| Q4 24 | 4.1% | 1.7% | ||
| Q3 24 | 0.5% | 0.4% | ||
| Q2 24 | 2.1% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 7.89× | — | ||
| Q3 25 | 1.58× | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 0.79× | — | ||
| Q4 24 | 2.77× | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 2.61× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NBBK
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
